The ribonucleotide reductase regulatory subunit m2 (RRM2) gene, which is a part of the cell cycle and p53 signaling pathway, is also known to be overexpressed in CRC [18], and has been correlated with the poorly differentiated type, invasion depth, and tumor node metastasis stages in CRC [18]. The gene discussed is TP53; the disease is neoplasm.